Industry
Medical - Devices
Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions, as well as markets regenerative non-tissue biologic solutions derived from synthetic materials. The Global Orthopedics segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
Loading...
Open
18.97
Mkt cap
712M
Volume
23K
High
18.97
P/E Ratio
-5.85
52-wk high
19.47
Low
18.66
Div yield
N/A
52-wk low
9.57
Portfolio Pulse from Benzinga Newsdesk
August 06, 2024 | 11:05 am
Portfolio Pulse from Benzinga Newsdesk
May 09, 2024 | 12:23 pm
Portfolio Pulse from Benzinga Newsdesk
May 08, 2024 | 9:50 am
Portfolio Pulse from Benzinga Newsdesk
May 07, 2024 | 12:12 pm
Portfolio Pulse from Benzinga Newsdesk
May 07, 2024 | 12:07 pm
Portfolio Pulse from Benzinga Newsdesk
April 22, 2024 | 4:31 pm
Portfolio Pulse from Benzinga Newsdesk
March 07, 2024 | 3:29 pm
Portfolio Pulse from Benzinga Newsdesk
March 06, 2024 | 4:53 pm
Portfolio Pulse from Benzinga Newsdesk
March 05, 2024 | 10:13 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.